We Finally Know What Drives Chronic Fatigue Syndrome (and Long-Covid)
The most convincing breakthrough yet in the key pathomechanisms (patho- means disease) involved.
The most convincing breakthrough yet in the key pathomechanisms (patho- means disease) involved.
Despite growing public interest in death, support for end-of-life care and bereavement remains inadequate. We urgently need a community centred, public health approach to the…
CheckMate 67T (NCT04810078) is a multicenter, randomized, open-label, phase 3 trial of NIVO SC vs IV in previously treated pts with advanced/metastatic ccRCC. In the…
Gene therapy for Diamond-Blackfan anemia is constrained by dozens of causative mutations. Voit and colleagues develop a universal gene therapy through erythroid-lineage-restricted expression of GATA1…
Edited by Associate Editor Michael Hallek and Podcast Editor Laurie H. Sehn, this Review Series highlights the biologic features of, clinical phenotype of,
Background Orthopaedic surgeon engagement with patient-reported outcome measures (PROMs) data has not been comprehensively evaluated, despite increasing uptake of orthopaedic PROMs programmes globally. The aim…
In this insightful episode of the Dr. Geo Prostate Podcast, Dr. Geo Espinosa sits down with Dr. Jun Gong, a leading medical oncologist at Cedars…
Research To Practice (RTP) is pleased to offer these complimentary 1-hour CME/MOC-accredited virtual sessions. Each session will be moderated by Dr Neil Love and feature…
The OncoAlert Newsletter is now out for June 23-29, 2023
Explore the program for the AACR Special Conference in Cancer Research: Translating Targeted Therapies in Combination with Radiotherapy.
Mathew discusses GP access to magnetic resonance imaging (MRI).1 Multiple studies have been published in which patients without symptoms underwent MRI of the knee and…